Cargando…
Pirfenidone gel in patients with localized scleroderma: a phase II study
INTRODUCTION: Localized scleroderma is an inflammatory disease in its first stages and a fibrotic process in later stages, principally mediated by the transforming growth factor β. To date, there is no standard treatment. The objective of this study was to determine the effectiveness and safety of 8...
Autores principales: | Rodríguez-Castellanos, Marco, Tlacuilo-Parra, Alberto, Sánchez-Enríquez, Sergio, Vélez-Gómez, Ezequiel, Guevara-Gutiérrez, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310025/ https://www.ncbi.nlm.nih.gov/pubmed/25533576 http://dx.doi.org/10.1186/s13075-014-0510-4 |
Ejemplares similares
-
Psoriasiform skin reaction due to Brazilian keratin treatment: A clinical-dermatoscopic study of 43 patients
por: Sanchez-Duenas, Luis Enrique, et al.
Publicado: (2022) -
Role and New Insights of Pirfenidone in Fibrotic Diseases
por: Lopez-de la Mora, David Alejandro, et al.
Publicado: (2015) -
Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration
por: Ikeda, Satoshi, et al.
Publicado: (2022) -
Surgical Management of Localized Scleroderma
por: Lee, Jae Hyun, et al.
Publicado: (2017) -
Immunopathogenesis of Pediatric Localized Scleroderma
por: Torok, Kathryn S., et al.
Publicado: (2019)